Total Revenue Growth
Total revenue for Q3 2025 was $37.3 million, representing an increase of 101% compared to $18.5 million in Q3 2024.
Greenbrook Clinics Performance
Greenbrook clinics generated $21.8 million in revenue, up 25% on an adjusted pro forma basis compared to the prior year quarter.
SPRAVATO Rollout Progress
SPRAVATO rollout remains on track with 84 of 89 eligible clinics now offering the therapy.
Cash Flow Improvement
Cash used in operations for Q3 was $0.8 million, a significant improvement from $17 million in Q1.
Adolescent Treatment Uptick
An increase in adolescent patient starts was noted, driven by the provider connection network.